Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126526683 | 12652668 | 3 | F | 2016 | 20160921 | 20160815 | 20160926 | EXP | CA-IPSEN BIOPHARMACEUTICALS, INC.-2016-06792 | IPSEN | 63.53 | YR | M | Y | 106.59000 | KG | 20160926 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126526683 | 12652668 | 1 | PS | SOMATULINE AUTOGEL | LANREOTIDE ACETATE | 1 | Unknown | 120 MG | N | L08556/L03433 | 0 | 120 | MG | SOLUTION FOR INJECTION/INFUSION | |||||
| 126526683 | 12652668 | 2 | SS | OCTREOTIDE. | OCTREOTIDE | 1 | Subcutaneous | 0 | 150 | MG | TID | ||||||||
| 126526683 | 12652668 | 3 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | 0 | ||||||||||||
| 126526683 | 12652668 | 4 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 126526683 | 12652668 | 5 | C | LASIX | FUROSEMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126526683 | 12652668 | 1 | Neuroendocrine tumour |
| 126526683 | 12652668 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126526683 | 12652668 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126526683 | 12652668 | Contusion | |
| 126526683 | 12652668 | Drug ineffective | |
| 126526683 | 12652668 | Inappropriate schedule of drug administration | |
| 126526683 | 12652668 | Increased tendency to bruise | |
| 126526683 | 12652668 | Lymphoedema | |
| 126526683 | 12652668 | Metastases to liver | |
| 126526683 | 12652668 | Skin abrasion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126526683 | 12652668 | 1 | 20160628 | 20160819 | 0 |